We are live on ! Find out more
DMIIR

Drugs Made In America Acquisition II Corp Right
DMIIR

61 hedge funds and large institutions have $3.29M invested in Drugs Made In America Acquisition II Corp Right in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more funds holding

Funds holding: 5761 (+4)

1% more capital invested

Capital invested by funds: $3.25M → $3.29M (+$35.1K)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

Holders
61
Holders Change
+4
Holders Change %
+7.02%
% of All Funds
0.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
8
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MF
1
Magnetar Financial
Illinois
$228K
Toronto Dominion Bank
2
Toronto Dominion Bank
Ontario, Canada
$216K +$960 +11,227 +0.4%
MI
3
MMCAP International
Cayman Islands
$216K
Millennium Management
4
Millennium Management
New York
$160K
GCL
5
Glazer Capital LLC
New York
$152K
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
6
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$145K
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$124K +$3.79K +44,300 +3%
TCM
8
Tenor Capital Management
New York
$120K
AC
9
Aristeia Capital
Connecticut
$108K
HIM
10
HGC Investment Management
Ontario, Canada
$98.5K
Hudson Bay Capital Management
11
Hudson Bay Capital Management
Connecticut
$95.5K -$33.5K -391,302 -23%
AA
12
AQR Arbitrage
Connecticut
$85.6K +$1.61K +18,876 +2%
HCM
13
Highbridge Capital Management
New York
$81.7K
DKCM
14
Davidson Kempner Capital Management
New York
$80K
LA
15
Linden Advisors
New York
$76K
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$72.7K
OAC
17
OMERS Administration Corp
Ontario, Canada
$72.7K
PMAM
18
Picton Mahoney Asset Management
Ontario, Canada
$70K
CL
19
CSS LLC
Illinois
$64.5K
CCM
20
Context Capital Management
California
$60K
MCS
21
Mercuria Capital Strategies
Texas
$60K
MCM
22
Moore Capital Management
New York
$60K
GCM
23
Ghisallo Capital Management
Massachusetts
$54.5K
RCM
24
Radcliffe Capital Management
Pennsylvania
$48.6K
SAMU
25
SONA Asset Management (US)
New York
$44K +$21.4K +250,000 +83%

DMIIR Hedge Fund Activity: Q2 2026 in Review

61 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp Right (DMIIR) for Q2 2026, worth a combined $3.29M — up 1.1% from $3.25M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new DMIIR positions and 0 closed out — a net gain of 4 holders — while 6 added to existing stakes and 8 trimmed.

The largest buyer was TIG Advisors LLC, opening a new position worth an estimated $42.8K. The largest seller was Hudson Bay Capital Management, cutting an estimated $33.5K.

  • 61 institutional investors held Drugs Made In America Acquisition II Corp Right (DMIIR) as of Q2 2026, up from 57 in Q1 2026.
  • Funds reported $3.29M of Drugs Made In America Acquisition II Corp Right stock for Q2 2026, up 1.1% quarter-over-quarter.
  • 4 funds opened new Drugs Made In America Acquisition II Corp Right positions in Q2 2026 and 0 closed out, a net change of +4 holders.
  • The largest Drugs Made In America Acquisition II Corp Right buyer in Q2 2026 was TIG Advisors LLC, an estimated $42.8K added.
  • The largest Drugs Made In America Acquisition II Corp Right seller in Q2 2026 was Hudson Bay Capital Management, an estimated $33.5K sold.

Based on aggregated 13F filings for Q2 2026.